SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 23, 2003
CardioGenesis Corporation
| California (State or Other Jurisdiction of Incorporation) |
000-28288 (Commission File Number) |
77-0223740 (IRS Employer Identification No.) |
| 26632 Towne Centre Drive, Suite 320, | ||
| Foothill Ranch, California (Address of Principal Executive Offices) |
92610 (Zip Code) |
| Registrant’s telephone number, including area code: | (714) 649-5000 | |
|
|
| Item 7. Financial Information, Pro Forma Financial Information and Exhibits | ||||||||
| Item 9. Regulation FD Disclosure | ||||||||
| SIGNATURE | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 7. Financial Information, Pro Forma Financial Information and Exhibits
(a) Not applicable.
(b) Not applicable.
(c) Exhibits:
| Pursuant to General Instruction F of Form 8-K, the following documents are incorporated by reference herein and attached as exhibits hereto: |
| Exhibit | Description | |
| 99.1 | Press Release of CardioGenesis Corporation, dated April 23, 2003. |
Item 9. Regulation FD Disclosure
In accordance with the guidance provided by the Securities and Exchange Commission in Securities Act Release No. 33-8216, the information in this Current Report on Form 8-K, including the exhibit, which is intended to be furnished pursuant to Item 12 of Form 8-K, is instead being furnished pursuant to Item 9, and shall not be deemed “filed” under the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities thereunder. Furthermore, the information in this Current Report on Form 8-K, including the exhibit, shall not be deemed to be incorporated by reference into the filings of the Registrant under the Securities Act of 1933, as amended.
On April 23, 2003, the Registrant issued a press release announcing its earnings for the quarter ended March 31, 2003. A copy of that release is furnished as Exhibit 99.1 to this report.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.
| CARDIOGENESIS CORPORATION | ||||
| Date: May 2, 2003 | By: | /s/ DARRELL F. ECKSTEIN
Darrell F. Eckstein President, Chief Operating Officer and Acting Chief Financial Officer |
EXHIBIT INDEX
| Exhibit | Description | |
| 99.1 | Press Release of CardioGenesis Corporation, dated April 23, 2003. |